During the state visit to India by the high-level Vietnamese delegation led by General Secretary and President To Lam, the health sectors of both nations officially signed a pivotal cooperation document on pharmaceutical management. This marks a concrete step in strengthening the Enhanced Comprehensive Strategic Partnership between the two countries.
Establishing a legal framework and quality oversight On May 6, 2026, in New Delhi, the Vietnamese Minister of Health and India’s Minister of Health and Family Welfare exchanged a Memorandum of Understanding (MoU) between the Drug Administration of Vietnam and the Central Drugs Standard Control Organization (CDSCO) of India.
-
Objectives: To establish a regular dialogue mechanism and enhance state regulatory capacity in the pharmaceutical field.
-
Key focuses: Both parties agreed to share information on legal frameworks, coordinate market surveillance, oversee drug quality and safety, and strengthen pharmacovigilance.
-
International coordination: Increasing collaboration and consensus at global multilateral health forums.
Strategic value for the healthcare sector This partnership is of significant practical importance as India remains a global powerhouse in vaccine and pharmaceutical manufacturing. The cooperation will support Vietnam in refining its medical legal corridor while ensuring the supply of high-quality medicines for its citizens.
Expanding opportunities for businesses Healthcare and pharmaceuticals have been identified as priority pillars in bilateral trade, which currently totals approximately $15-16 billion annually. The new agreement is expected to stimulate trade, research, and development activities among pharmaceutical enterprises from both nations, building on the effective coordination experienced during the COVID-19 pandemic response.